Wonder Club world wonders pyramid logo
×

Heart Failure: Molecules, Mechanisms and Therapeutic Targets Book

Heart Failure: Molecules, Mechanisms and Therapeutic Targets
Heart Failure: Molecules, Mechanisms and Therapeutic Targets, Heart failure is the main cause of death and disability in the industrialized world. There is a major need for novel therapeutics for prevention and reversal of cardiac pathology associated with heart failure and cardiac enlargement. Over recent years, dr, Heart Failure: Molecules, Mechanisms and Therapeutic Targets has a rating of 5 stars
   2 Ratings
X
Heart Failure: Molecules, Mechanisms and Therapeutic Targets, Heart failure is the main cause of death and disability in the industrialized world. There is a major need for novel therapeutics for prevention and reversal of cardiac pathology associated with heart failure and cardiac enlargement. Over recent years, dr, Heart Failure: Molecules, Mechanisms and Therapeutic Targets
5 out of 5 stars based on 2 reviews
5
100 %
4
0 %
3
0 %
2
0 %
1
0 %
Digital Copy
PDF format
1 available   for $196.80
Original Magazine
Physical Format

Sold Out

  • Heart Failure: Molecules, Mechanisms and Therapeutic Targets
  • Written by author Novartis Foundation
  • Published by Wiley, John & Sons, Incorporated, September 2006
  • Heart failure is the main cause of death and disability in the industrialized world. There is a major need for novel therapeutics for prevention and reversal of cardiac pathology associated with heart failure and cardiac enlargement. Over recent years, dr
  • Heart failure is the main cause of death and disability in the industrialized world. There is a major need for novel therapeutics for prevention and reversal of cardiac pathology associated with heart failure and cardiac enlargement. Over recent years, dr
Buy Digital  USD$196.80

WonderClub View Cart Button

WonderClub Add to Inventory Button
WonderClub Add to Wishlist Button
WonderClub Add to Collection Button

Book Categories

Authors

Symposium on Heart failure: molecules, mechanisms and therapeutic targets, held at the Novartis Foundation, 26-28 April 2005
Editors: Gregory Bock (Organizer) and Jamie Goode
This symposium is based on a proposal made by Eric N. Olson
Introduction     1
Control of cardiac hypertrophy and heart failure by histone acetylation/deacetylation     3
Discussion     13
A novel mechanism of mechanical stress-induced hypertrophy     20
Discussion     31
Controlling cardiomyocyte survival     41
Discussion     51
Mechanisms of angiotensin Il-dependent progression to heart failure     58
Discussion     68
Alterations in myocardial gene expression as a basis for cardiomyopathies and heart failure     73
Discussion     83
Role of the insulin-like growth factor 1 (IGF1)/phosphoinositide-3-kinase (PI3K) pathway mediating physiological cardiac hypertrophy     90
Discussion     111
Role of Akt in cardiac growth and metabolism     118
Discussion     126
Novel therapy for heart failure and exercise-induced ventricular tachycardia based on 'fixing' the leak in ryanodine receptors     132
Discussion     147
General discussion I     152
Phospholamban as a therapeutic modality in heart failure     156
Discussion     172
Sarcomere protein gene mutations and inherited heart disease: a [Beta]-cardiac myosin heavy chain mutation causing endocardial fibroelastosis and heart failure     176
Discussion     189
The cardiomyocyte cell cycle     196
Discussion     208
Restoration of cardiac function with progenitor cells     214
Discussion     223
Signalling pathways in cardiac regeneration     228
Discussion     239
Beyond small molecule drugs for heart failure: prospects for gene therapy     244
Discussion     256
Dual roles of telomerase in cardiac protection and repair     260
Discussion     267
Final general discussion     272
Closing remarks: historical perspective     277
Index of contributors     280
Subject index     282


Login

  |  

Complaints

  |  

Blog

  |  

Games

  |  

Digital Media

  |  

Souls

  |  

Obituary

  |  

Contact Us

  |  

FAQ

CAN'T FIND WHAT YOU'RE LOOKING FOR? CLICK HERE!!!

X
WonderClub Home

This item is in your Wish List

Heart Failure: Molecules, Mechanisms and Therapeutic Targets, Heart failure is the main cause of death and disability in the industrialized world. There is a major need for novel therapeutics for prevention and reversal of cardiac pathology associated with heart failure and cardiac enlargement. Over recent years, dr, Heart Failure: Molecules, Mechanisms and Therapeutic Targets

X
WonderClub Home

This item is in your Collection

Heart Failure: Molecules, Mechanisms and Therapeutic Targets, Heart failure is the main cause of death and disability in the industrialized world. There is a major need for novel therapeutics for prevention and reversal of cardiac pathology associated with heart failure and cardiac enlargement. Over recent years, dr, Heart Failure: Molecules, Mechanisms and Therapeutic Targets

Heart Failure: Molecules, Mechanisms and Therapeutic Targets

X
WonderClub Home

This Item is in Your Inventory

Heart Failure: Molecules, Mechanisms and Therapeutic Targets, Heart failure is the main cause of death and disability in the industrialized world. There is a major need for novel therapeutics for prevention and reversal of cardiac pathology associated with heart failure and cardiac enlargement. Over recent years, dr, Heart Failure: Molecules, Mechanisms and Therapeutic Targets

Heart Failure: Molecules, Mechanisms and Therapeutic Targets

WonderClub Home

You must be logged in to review the products

E-mail address:

Password: